VPS35 promotes cell proliferation via EGFR recycling and enhances EGFR inhibitors response in gastric cancer-Reference-Cited by-同舟云学术

VPS35 promotes cell proliferation via EGFR recycling and enhances EGFR inhibitors response in gastric cancer

Published:2023-03 Issue: Volume:89 Page:104451
ISSN:2352-3964
Container-title:eBioMedicine
language:en
Short-container-title:eBioMedicine

Author:

Yu Junxian,Feng Haoran,Sang Qingqing,Li Fangyuan,Chen Mengdi,Yu Beiqin,Xu Zhuoqing,Pan Tao,Wu Xiongyan,Hou Junyi,Zhu Zhenggang,Yan Chao,Su Liping,Li Jianfang,Liu Bingya^ORCID

Funder

Natural Science Foundation of Shanghai

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference43 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Cancer statistics, 2021;Siegel;CA Cancer J Clin,2021

3. Current treatment and recent progress in gastric cancer;Joshi;CA A Cancer J Clin,2021

4. Regorafenib plus nivolumab in patients with advanced gastric or colorectal cancer: an open-label, dose-escalation, and dose-expansion phase Ib trial (REGONIVO, EPOC1603);Fukuoka;J Clin Oncol,2020

5. Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens;Behan;Nature,2019

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EGFR mutations and abnormal trafficking in cancers;Molecular Biology Reports;2024-08-21

2. Erlotinib Treatment in Colorectal Cancer Suppresses Autophagy Based on KRAS Mutation;Current Issues in Molecular Biology;2024-07-16

3. Molecular Mechanisms of Buzhong Yiqi Decoction in the Treatment of Gastric Cancer: A Network Pharmacology, Molecular Docking, and In Vitro Experimental Analysis;Peptide Science;2024-07-04

4. A systematic computational analysis of the endosomal recycling pathway in glioblastoma;Biochemistry and Biophysics Reports;2024-07

5. Gastric Cancer Assembloids Derived from Patient‐Derived Xenografts: A Preclinical Model for Therapeutic Drug Screening;Small Methods;2024-07